Experiences with Glucagon-Like Peptide-1 Receptor Agonist in Children with Acquired Hypothalamic Obesity
Conclusions: In this small cohort, we found little effect of GLP-1 receptor agonist in the treatment for acquired HO. Future research should focus on the prevention of HO or, if prevention is not possible, on alternative, individualized interventions.Obes Facts
Source: Obesity Facts - Category: Eating Disorders & Weight Management Source Type: research
More News: Brain | Brain Cancers | Brain Tumor | Byetta | Children | Diets | Eating Disorders & Weight Management | Neurology | Nutrition | Obesity | Pain | Study | Weight Loss